Scandinavian Real Heart AB (Publ) (HEART.ST)

SEK 12.54

(-2.79%)

Market Cap (In SEK)

25.93 Million

Revenue (In SEK)

-

Net Income (In SEK)

-67.97 Million

Avg. Volume

518.96 Thousand

Currency
SEK
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
11.7-65.52929
PE
-
EPS
-
Beta Value
0.101
ISIN
SE0006256798
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Ina Laura Perkins
Employee Count
-
Website
https://realheart.se
Ipo Date
2014-11-26
Details
Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.